These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29785524)

  • 21. The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study.
    Hébert LJ; Remec JF; Saulnier J; Vial C; Puymirat J
    BMC Musculoskelet Disord; 2010 Apr; 11():72. PubMed ID: 20398425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of motor function and muscle strength in the congenital and childhood forms of myotonic dystrophy type 1.
    Kroksmark AK; Stridh ML; Ekström AB
    Neuromuscul Disord; 2017 Sep; 27(9):826-835. PubMed ID: 28673557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The strength of the ankle dorsiflexors has a significant contribution to walking speed in people who can walk independently after stroke: an observational study.
    Dorsch S; Ada L; Canning CG; Al-Zharani M; Dean C
    Arch Phys Med Rehabil; 2012 Jun; 93(6):1072-6. PubMed ID: 22464738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal muscle involvement in myotonic dystrophy type 2. A comparative muscle ultrasound study.
    Tieleman AA; Vinke A; van Alfen N; van Dijk JP; Pillen S; van Engelen BG
    Neuromuscul Disord; 2012 Jun; 22(6):492-9. PubMed ID: 22414627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does quantitative EMG differ myotonic dystrophy type 2 and type 1?
    Szmidt-Salkowska E; Gawel M; Lusakowska A; Nojszewska M; Lipowska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    J Electromyogr Kinesiol; 2014 Oct; 24(5):755-61. PubMed ID: 25052913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What Happened with Muscle Force, Dynamic Stability And Falls? A 10-Year Longitudinal Follow-Up in Adults with Myotonic Dystrophy Type 1.
    Hammarén E; Kollén L
    J Neuromuscul Dis; 2021; 8(6):1007-1016. PubMed ID: 34151851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1.
    Bachasson D; Moraux A; Ollivier G; Decostre V; Ledoux I; Gidaro T; Servais L; Behin A; Stojkovic T; Hébert LJ; Puymirat J; Eymard B; Bassez G; Hogrel JY
    Neuromuscul Disord; 2016 Jul; 26(7):428-35. PubMed ID: 27234310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-Rater Reliability and Concurrent Validity of Quantified Muscle Testing for Maximal Knee Extensors Strength in Men with Myotonic Dystrophy Type 1.
    Roussel MP; Hébert LJ; Duchesne E
    J Neuromuscul Dis; 2019; 6(2):233-240. PubMed ID: 31127731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study.
    Gallais B; Gagnon C; Mathieu J; Richer L
    Neuromuscul Disord; 2017 Jan; 27(1):61-72. PubMed ID: 27919548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification.
    De Antonio M; Dogan C; Hamroun D; Mati M; Zerrouki S; Eymard B; Katsahian S; Bassez G;
    Rev Neurol (Paris); 2016 Oct; 172(10):572-580. PubMed ID: 27665240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-sectional association between muscle strength and self-reported physical function in 195 hip osteoarthritis patients.
    Hall M; Wrigley TV; Kasza J; Dobson F; Pua YH; Metcalf BR; Bennell KL
    Semin Arthritis Rheum; 2017 Feb; 46(4):387-394. PubMed ID: 27665019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Threshold of lower body muscular strength necessary to perform ADL independently in community-dwelling older adults.
    Hasegawa R; Islam MM; Lee SC; Koizumi D; Rogers ME; Takeshima N
    Clin Rehabil; 2008; 22(10-11):902-10. PubMed ID: 18955422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Nine Hole Peg Test as a measure of dexterity in myotonic dystrophy type 1.
    Cutellè C; Rastelli E; Gibellini M; Greco G; Frezza E; Botta A; Terracciano C; Massa R
    Neuromuscul Disord; 2018 Nov; 28(11):947-951. PubMed ID: 30270126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central and peripheral components of exercise-related fatigability in myotonic dystrophy type 1.
    Boërio D; Lefaucheur JP; Bassez G; Hogrel JY
    Acta Neurol Scand; 2012 Jan; 125(1):38-46. PubMed ID: 22188374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower Extremity Muscle Strength and Force Variability in Persons With Parkinson Disease.
    Skinner JW; Christou EA; Hass CJ
    J Neurol Phys Ther; 2019 Jan; 43(1):56-62. PubMed ID: 30531387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review.
    Roussel MP; Morin M; Gagnon C; Duchesne E
    BMC Musculoskelet Disord; 2019 Mar; 20(1):101. PubMed ID: 30836978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of neuromuscular performances in adults with late-onset Pompe disease: A control case cross-sectional study.
    Maulet T; Bonnyaud C; Laforêt P; Cattagni T
    Neuromuscul Disord; 2023 Dec; 33(12):923-935. PubMed ID: 37989689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes.
    Sansone VA; Brigonzi E; Schoser B; Villani S; Gaeta M; De Ambroggi G; Bandera F; De Ambroggi L; Meola G
    Int J Cardiol; 2013 Sep; 168(2):1147-53. PubMed ID: 23266299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower-extremity strength profiles and gender-based classification of basketball players ages 9-22 years.
    Buchanan PA; Vardaxis VG
    J Strength Cond Res; 2009 Mar; 23(2):406-19. PubMed ID: 19209081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.